Literature DB >> 22622167

Morvan syndrome: a case report and review of the literature.

Elias Abou-Zeid1, Lana Jeradeh Boursoulian, Walter S Metzer, Betul Gundogdu.   

Abstract

Morvan syndrome is characterized by central, autonomic, and peripheral hyperactivity. Examples of central hyperactivity include confusion, memory problems, hallucinations, insomnia, and myoclonus; examples of autonomic hyperactivity include hyperhidrosis and fluctuations in blood pressure; examples of peripheral hyperreactivity include clinical or electrophysiological evidence of painful cramps, myokymia, and neuromyotonia. We present a typical case of Morvan syndrome and the first detailed review of the clinical and therapeutic literature of all 27 cases from the English language literature. Morvan syndrome is considered to be an autoimmune disorder and antibodies against voltage-gated potassium channels are found in most cases. Oral immunomodulatory therapy, intravenous immunoglobulin, and plasmapharesis may be entertained. Thymoma is found in approximately 50% of cases and thymectomy may be curative as in our particular case.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622167     DOI: 10.1097/CND.0b013e31822b1977

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  13 in total

Review 1.  Paraneoplastic disorders in thymoma patients.

Authors:  Amelia Evoli; Eric Lancaster
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

2.  Long-term clinical course with voltage-gated potassium channel antibody in Morvan's syndrome.

Authors:  Nam-Hee Kim; Angela Vincent; Saroshi R Irani; Sang Eun Kim; Kwang-Woo Lee; Kyung Seok Park
Journal:  J Neurol       Date:  2013-07-28       Impact factor: 4.849

Review 3.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

4.  Morvan's syndrome treated successfully with rituximab and lacosamide.

Authors:  Olafur Sveinsson; Faiez Al Nimer; Fredrik Piehl
Journal:  BMJ Case Rep       Date:  2019-02-13

5.  Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report.

Authors:  Edvina Galié; Rosaria Renna; Domenico Plantone; Andrea Pace; Mirella Marino; Bruno Jandolo; Tatiana Koudriavtseva
Journal:  Oncol Lett       Date:  2016-07-29       Impact factor: 2.967

6.  Morvan Syndrome: A Case Report With Patient Narrative and Video.

Authors:  Mark Maskery; Suresh K Chhetri; Rejith Dayanandan; Claire Gall; Hedley C A Emsley
Journal:  Neurohospitalist       Date:  2016-01

Review 7.  Current Treatment Options for Peripheral Nerve Hyperexcitability Syndromes.

Authors:  Cheran Elangovan; Adeolu Morawo; Aiesha Ahmed
Journal:  Curr Treat Options Neurol       Date:  2018-05-28       Impact factor: 3.972

8.  Morvan Syndrome Secondary to Thymic Carcinoma in a Patient with Systemic Lupus Erythematosus.

Authors:  Gabrielle Macaron; Elie El Rassy; Salam Koussa
Journal:  Case Rep Neurol Med       Date:  2016-05-10

9.  Morvan syndrome: a rare cause of syndrome of inappropriate antidiuretic hormone secretion.

Authors:  Seref Demirbas; Musa Baris Aykan; Haydar Zengin; Semir Mazman; Kenan Saglam
Journal:  Clujul Med       Date:  2017-07-15

10.  A Case of Morvan's Syndrome Associated with Heavy Metal Poisoning after Ayurvedic Drug Intake.

Authors:  S Mohanakkannan; Sowmini R Perumal; Sakthi Velayudham; K Malcolm Jeyaraj; S Arunan
Journal:  J Neurosci Rural Pract       Date:  2018 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.